|
1
|
Szyszka-Barth K, Ramlau K,
Goździk-Spychalska J, et al: Actual status of therapeutic
vaccination in non-small cell lung cancer. Contemp Oncol (Pozn).
18:77–84. 2014.
|
|
2
|
Lin Y, Shi R, Wang X and Shen HM:
Luteolin, a flavonoid with potentials for cancer prevention and
therapy. Curr Cancer Drug Targets. 8:634–646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin Y, Shi R, Wang X and Shen HM:
Luteolin, a flavonoid with potential for cancer prevention and
therapy. Curr Cancer Drug Targets. 8:634–646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Asgarpanah J and Kazemivash N:
Phytochemistry, pharmacology and medicinal properties of Carthamus
tinctorius L. Chin J Integr Med. 19:153–159. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cai X, Ye T, Liu C, et al: Luteolin
induced G2 phase cell cycle arrest and apoptosis on non-small cell
lung cancer cells. Toxicol In Vitro. 25:1385–1391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heltweg B, Gatbonton T, Schuler AD, et al:
Antitumor activity of a small-molecule inhibitor of human silent
information regulator 2 enzymes. Cancer Res. 66:4368–4377. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen HC, Jeng YM, Yuan RH, Hsu HC and Chen
YL: SIRT1 promotes tumorigenesis and resistance to chemotherapy in
hepatocellular carcinoma and its expression predicts poor
prognosis. Ann Surg Oncol. 19:2011–2019. 2012. View Article : Google Scholar
|
|
8
|
Pang WJ, Xiong Y, Wang Y, Tong Q and Yang
GS: Sirt1 attenuates camptothecin-induced apoptosis through
caspase-3 pathway in porcine preadipocytes. Exp Cell Res.
319:670–683. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yi J and Luo J: SIRT1 and p53, effect on
cancer, senescence and beyond. Biochim Biophys Acta. 1804:1684–9.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao Z and Ye J: Inhibition of
transcriptional activity of c-JUN by SIRT1. Biochem Biophys Res
Commun. 376:793–796. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi H, Wang J, Dong F, Wang X, Li H and
Hou Y: The effect of proteoglycans inhibited by RNA interference on
metastatic characters of human salivary adenoid cystic carcinoma.
BMC Cancer. 9:4562009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Daoud A, Song J, Xiao F and Shang J:
B-9-3, a novel beta-carboline derivative exhibits anti-cancer
activity via induction of apoptosis and inhibition of cell
migration in vitro. Eur J Pharmacol. 724:219–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method[J]. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
14
|
Yamaguchi H, Wyckoff J and Condeelis J:
Cell migration in tumors. Curr Opin Cell Biol. 17:559–564. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sahai A, Mallina R, Dowson C, Larner T and
Khan MS: Evolution of transdermal oxybutynin in the treatment of
overactive bladder. Int J Clin Pract. 62:167–170. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park SH, Park HS, Lee JH, et al: Induction
of endoplasmic reticulum stress-mediated apoptosis and
non-canonical autophagy by luteolin in NCI-H460 lung carcinoma
cells. Food Chem Toxicol. 56:100–109. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kollipara PS, Jeong HS, Han SB and Hong
JT: (E)-2,4-bis (p-hydroxyphenyl)-2-butenal has an
antiproliferative effect on NSCLC cells induced by p38
MAPK-mediated suppression of NF-kappaB and up-regulation of
TNFRSF10B (DR5). Br J Pharmacol. 168:1471–1484. 2013. View Article : Google Scholar :
|
|
18
|
Yeung F, Hoberg JE, Ramsey CS, et al:
Modulation of NF-κB-dependent transcription and cell survival by
the SIRT1 deacetylase. EMBO J. 23:2369–2380. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun Y, Sun D, Li F, et al: Downregulation
of Sirt1 by antisense oligonucleotides induces apoptosis and
enhances radiation sensitization in A549 lung cancer cells. Lung
Cancer. 58:21–29. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen MC, Chen CH, Liu YN, Wang HP, Pan SL
and Teng CM: TW01001, a novel piperazinedione compound, induces
mitotic arrest and autophagy in non-small cell lung cancer A549
cells. Cancer Lett. 336:370–378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chian S, Thapa R, Chi Z, Wang XJ and Tang
X: Luteolin inhibits the Nrf2 signaling pathway and tumor growth in
vivo. Biochem Biophys Res Commun. 447:602–608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bai L, Xu X, Wang Q, et al: A
superoxide-mediated mitogen-activated protein kinase phosphatase-1
degradation and c-Jun NH2-terminal kinase activation pathway for
luteolin-induced lung cancer cytotoxicity. Mol Pharmacol.
81:549–555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Solomon JM, Pasupuleti R, Xu L, et al:
Inhibition of SIRT1 catalytic activity increases p53 acetylation
but does not alter cell survival following DNA damage. Mol Cell
Biol. 26:28–38. 2006. View Article : Google Scholar :
|
|
24
|
Liu X, Shao K and Sun T: SIRT1 regulates
the human alveolar epithelial A549 cell apoptosis induced by
Pseudomonas aeruginosa lipopolysaccharide. Cell Physiol Biochem.
31:92–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
